---
title: "Oritavancin - Staphylococcal infection of skin"
sidebar: mydoc_sidebar
permalink: db04911-mesh-d013207-1.html
toc: false 
---


Path ID: `DB04911_MESH_D013207_1`
{% include image.html url="images/db04911-mesh-d013207-1.png" file="db04911-mesh-d013207-1.png" alt="db04911-mesh-d013207-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C100708 | Oritavancin | Drug |
| GO:0009273 | Peptidoglycan-based cell wall biogenesis | BiologicalProcess |
| GO:0051301 | Cell division | BiologicalProcess |
| NCBITaxon:280 | Staphylococcus aureus | OrganismTaxon |
| MESH:D013207 | Staphylococcal infection of skin | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Oritavancin | NEGATIVELY REGULATES | Peptidoglycan-Based Cell Wall Biogenesis |
| Peptidoglycan-Based Cell Wall Biogenesis | POSITIVELY CORRELATED WITH | Cell Division |
| Cell Division | IN TAXON | Staphylococcus Aureus |
| Staphylococcus Aureus | CAUSES | Staphylococcal Infection Of Skin |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB04911#BE0009914](https://go.drugbank.com/drugs/DB04911#BE0009914)
